F. Hoffmann-La Roche Ltd (ROG) - Medical Equipment - Deals and Alliances Profile

Date: October 11, 2017
Pages: 225
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: F91A6AEE0EEEN
Leaflet:

Download PDF Leaflet

F. Hoffmann-La Roche Ltd (ROG) - Medical Equipment - Deals and Alliances Profile
Summary

F. Hoffmann-La Roche Ltd (Roche) develops drugs that improve the standard of care across major disease areas. It provides pharmaceuticals in cancer, neuroscience, infection, immunology, ophthalmology, cardiovascular and metabolism, immunology, hematology, hemophilia and respiratory disease areas. The company also provides in vitro diagnostics, tissue-based cancer diagnostics, as well as diabetes management solutions. Roche’s diagnostic products include clinical chemistry and immunoassays, molecular diagnostics, tissue diagnostics, point of care diagnostics, laboratory automation and IT solutions, urinalysis products, lab testing products, custom biotech solutions, patient self-testing products and solutions for life science. The company offers its products and services to hospitals, commercial diagnostic laboratories, healthcare professionals, researchers and pharmacists. Roche is headquartered in Basel, Switzerland.

F. Hoffmann-La Roche Ltd (ROG) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
  • The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
  • The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
  • Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
  • The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
  • Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
  • Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company.
F. Hoffmann-La Roche Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017
F. Hoffmann-La Roche Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017
F. Hoffmann-La Roche Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017
F. Hoffmann-La Roche Ltd, Medical Equipment, Deals By Market, 2011 to YTD 2017
F. Hoffmann-La Roche Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017
F. Hoffmann-La Roche Ltd, Medical Equipment, Deal Details
Asset Purchase
Roche Diagnostics to Acquire Tissue Dissection Technology from AvanSci Bio
Genentech Acquires NanoPrint LM60 Microarrayer Platform From Arrayit
Venture Financing
Viewics Raises Additional USD10.5 Million in Series B Venture Financing
Omicia Raises USD23 Million in Series B Financing Round
Cota Raises Funds through Venture Financing
Purigen Biosystems Raises USD18.2 Million in Series A Financing
Flatiron Health Raises USD175 Million in Series C Financing
mySugr Raises USD4.8 Million in Venture Financing
Curetis Raises USD18 Million in Extended Series B Venture Financing
GeneWeave Biosciences Raises USD12 Million in Series B Venture Financing
Curetis Raises US$16.3 Million In Series B Financing
MacuLogix Raises US$3.6 Million In Series A Financing
Foundation Medicine Raises US$56 Million In Series B Financing
GeneWeave Raises US$12 Million In Series A Financing Round
GeneWeave Biosciences Raises USD12 Million in Venrture Financing
Aria Diagnostics Secures US$52.7 Million In Series C Venture Financing
Ariosa Diagnostics Secures USD52.7 Million in Series C Funding Round
Curetis Secures Additional US$13.3 Million In Series A Venture Financing
Foundation Medicine Secures Additional US$8.5 Million In Series A Venture Financing
Foundation Medicine Raises US$10 Million In Venture Financing
Ambit Biosciences Secures US$30 Million In Series D-2 Financing
Partnerships
Genentech Enters into Licensing Agreement with Vital Art and Science
Roche Enters into Licensing Agreement with Becton Dickinson
Ariosa Diagnostics Enters into Licensing Agreement with Labs
Foundation Medicine Enters into Licensing Agreement with WuXi PharmaTech
Roche Enters Into Licensing Agreement With Sysmex Inostics For emPCR Patent Portfolio
Thermo Fisher Scientific Extends Licensing Agreement With Roche For Procalcitonin Test
Ventana Medical Systems Enters Into Licensing Agreement With Biocare Medical
Ventana Medical Enters Into Licensing Agreement With German Cancer Research Center And University Hospital Heidelberg For BRAF V600E
Ventana Medical Enters Into Licensing Agreement With Gen-Probe For IP Of ERG Marker
Roche Enters Into Licensing Agreement With Life Technologies For PCR Technology
Ventana Medical Systems Enters Into Licensing Agreement With Cell Signaling Technology
Research Ventures & Licensing Enters Into Licensing Agreement With Ventana Medical Systems
Cell Signaling Technology Enters Into Licensing Agreement With Ventana Medical Systems
Circadian Technologies Enters Into Licensing Agreement With Chugai Pharma
Mimetas and Roche Jointly Develops Gut-On-A-Chip Technology
Roche Enters into Agreement with Accenture
Senseonics Holdings Enters into Agreement with TypeZero and Roche Diabetes
Loxo Oncology Enters into Agreement with Ventana Medical Systems
Roche Diabetes Care Enters into Agreement with Medtronic
Good Start Genetics Enters into Marketing Agreement with Roche Diagnostics
Berkeley Lights Enters into Agreement with F. Hoffmann-La Roche
Roche Enters into Agreement with BARDA
Horizon Discovery Group Enters into Co-Development Agreement with Ventana Medical Systems
Foundation Medicine Enters into Agreement with AstraZeneca
Senseonics Amends its Distribution Agreement with F. Hoffmann-La Roche
Cellnovo Enters into Agreement with Roche Diagnostics
Blueprint Medicines Enters into Co-Development Agreement with Ventana Medical Systems
Foundation Medicine Enters into Agreement with Mirati Therapeutics
IMS Health Enters into Agreement with Foundation Medicine
Halozyme Therapeutics Enters into Co-Development Agreement with Ventana Medical Systems for Cancer Treatment
Foundation Medicine Enters into Co-Development Agreement with Flatiron Health
Molecular Devices Enters into Co-Development Agreement with Roche Diagnostics
Ventana Medical Systems Enters into Co-Development Agreement with ImmunoGen
AstraZeneca Enters into Co-Development Agreement with Roche
Advanced Biological Labs Extends Co-Promotion Agreement with Roche Diagnostics
Bioprocessing Tech Institute Enters Into Agreement with Roche to Develop Cancer Therapeutics
Ventana Medical Systems Enters into Co-Development Agreement with Merck Serono for Companion Diagnostic Test
AUT University Forms Joint Venture with Roche Diagnostics
Ventana Medical Enters into Co-Development Agreement with MedImmune
Ventana Medical Systems Enters Into Co-Development Agreement With Genmab
Foundation Medicine Extends Co-Development Agreement With Clovis Oncology
Ventana Extends Co-Development Agreement With Bayer Pharma
Foundation Medicine Expands Co-Development Agreement With Novartis
Ventana Medical Systems Enters Into Co-Development Agreement With Incyte For Companion Diagnostic Tests
Ventana Medical Systems Enters Into Agreement With Boehringer Ingelheim For Companion Diagnostic Tests
Ariosa Diagnostics Enters Into Agreement With Fleury For Harmony Prenatal Test
Genia Technologies Enters Into Agreement With Columbia University And Harvard Medical To Develop NanoTag DNA Sequencing Technology
Advanced Biological Labs And Roche Diagnostics Enter Into Agreement To Promote Sequencing, Genotyping And Drug Resistance Products
Ascendis Pharma Enters Into Collaboration Agreement with Genentech
Ventana Medical Systems And TGen Enter Into Agreement To Develop Cancer Diagnostic Markers
Ventana Medical And Barco Enter Into Agreement For Digital Pathology Imaging Platform
Foundation Medicine Enters Into Co-Development Agreement With Memorial Sloan-Kettering Cancer Center
Foundation Medicine Enters Into Agreement With Agios Pharma To Develop Cancer Diagnostics
Roche Enters Into Co-Development Agreement With BioLamina For Cell Culture Systems
Ariosa Diagnostics Enters Into Distribution Agreement With The Doctors Laboratory For Harmony Prenatal Test
Epizyme, Eisai And Roche Enter Into Co-Development Agreement For Companion Diagnostic Test
Roche Enters Into Co-Development Agreement With Precision System Science For PCR Instrument
NCM USA Enters Into Co-Development Agreement With Genentech For Clinical Imaging Agents
Foundation Medicine Enters Into Agreement With Eisai For Genomic Profiling And Diagnostic Discovery
Genia Technologies Enters Into Co-Development Agreement With Columbia University And Harvard University
Foundation Medicine Enters Into Co-Development Agreement With Clovis Oncology
Foundation Medicine Extends Co-Development Agreement With Novartis
Hycor Biomedical Enters Into Distribution Agreement With Roche For KOVA
Sysmex Extends Distribution Agreement With Roche
Seattle Genetics And Millennium Pharma Enter Into Co-Development Agreement With Ventana Medical Systems
Roche Enters Into Co-Development Agreement With Technoclone
Ventana Medical Systems Enters Into Co-Development Agreement With Bayer Pharma
Ventana Medical Systems Enters Into Co-Development Agreement With Pfizer
Foundation Medicine Enters Into Co-Development Agreement With Sanofi For Genetic Biomarkers And Potential Diagnostics
AEterna Zentaris Enters Into Co-Development Agreement With Ventana Medical Systems
Syndax Pharma Enters Into Co-Development Agreement With Ventana Medical Systems
Roche Enters Into Joint Venture Agreement With Swiss Federal Institute of Technology, University of Zurich And University Hospital Zurich
Roche Enters Into Technology Integration Agreement With Labcyte
reinnervate Enters Into Technology Integration Agreement With Mirus Bio
Roche Diagnostics Enters Into Research And Development Agreement With DexCom
Roche Diagnostics Enters Into Distribution Agreement With DexCom
Roche Enters Into Distribution Agreement With PerkinElmer
Roche NimbleGen Enters Into Co-Marketing Agreement With Caliper Life Sciences
Roche Enters Into Collaboration With Evotec
University of Geneva, Hopitaux Universitaires de Geneve, SIB And Roche Form Partnership
F. Hoffmann-La Roche Enters Into Co-Development Agreement With Merck
Roche Enters Into Co-Development Agreement With Clovis Oncology
Roche Applied Science Enters Into Partnership With TIB MOLBIOL
Roche Applied Science Enters Into Co-Marketing Agreement With IT-IS Life Sciences
Lonza Enters Into Distribution Agreement With Roche Applied Science
Foundation Medicine Enters Into An Agreement With Novartis
Sonic Healthcare Enters into Licensing Agreement with Ariosa Diagnostics
Roche Enters into Licensing Agreement with Dalcor Pharma
Roche Diagnostics Enters Into Licensing Agreement With Arizona Technology And Columbia University
MBM ScienceBridge Enters Into Licensing Agreement With Roche
Eppendorf Enters Into Licensing Agreement With F. Hoffmann-La Roche
Equity Offering
Foundation Medicine Raises USD250 Million in Private Placement of Shares
Ariosa Diagnostics Withdraws IPO
Foundation Medicine Withdraws Public Offering Of Shares For Up To US$150 Million
Foundation Medicine Completes IPO Of Shares For US$122 Million
Debt Offering
Roche Prices Public Offering of Bonds Due 2020 for USD600 Million
Roche Prices Public Offering of 0.875% Bonds Due 2025 for USD1.14 Billion
Roche Plans to Raise USD850 Million in Public Offering of Notes
Roche Plans to Raise USD500 Million in Public Offering of Bonds
Roche Plans to Raise USD1.3 Billion in Public Offering of Bonds Due 2021
Roche Plans to Raise USD1.3 Billion in Public Offering of Bonds Due 2024
Roche Plans to Raise USD300 Million in Public Offering of Bonds
Roche Plans to Raise USD1.5 Billion in Public Offering of Bonds
Asset Transactions
Roche Rumored To Sell Its Diabetes Device Unit
SynenTec To Acquire Cellavista Systems Business From Roche
Acquisition
Roche Acquires mySugr for USD73.1 Million
Roche Acquires ForSight VISION4 from ForSight Labs
Novartis Plans to Sell its Stake in F. Hoffmann-La Roche
Roche Acquires GeneWEAVE BioSciences for USD350 Million
Roche Acquires CAPP Medical
Roche Acquires Signature Diagnostics
Roche Acquires Ariosa Diagnostics
Roche Acquires Bina Technologies
F. Hoffmann-La Roche Completes Acquisition of Iquum for USD450 Million
Roche Diagnostics Acquires Genia for up to USD350 Million
Fluidigm Completes Acquisition Of DVS Sciences For US$207.5 Million
Roche Rumored To Acquire BioMarin Pharma For US$13.5 Billion
Roche Acquires Constitution Medical For US$220 Million
Celltrion Chairman Jung Jin Seo Plans To Sell Controlling Stake In The Company
Roche Completes Acquisition Of Verum Diagnostica For US$15 Million
Roche Completes Acquisition Of mtm Labs
Roche Completes Acquisition Of PVT Probenverteiltechnik And PVT Lab Systems For US$126.14 Million
F. Hoffmann-La Roche Ltd - Key Competitors
F. Hoffmann-La Roche Ltd - Key Employees
F. Hoffmann-La Roche Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Financial Announcements
Jul 27, 2017: Roche reports strong performance in the first half of 2017
Apr 27, 2017: Roche reports a good start in 2017
Feb 01, 2017: Roche reports good results in 2016
Oct 20, 2016: Roche delivers good sales growth in the first nine months of 2016
Jul 21, 2016: Roche delivers continued growth in the first half of 2016
Jan 28, 2016: Roche reports strong results in 2015
Corporate Communications
Sep 07, 2017: Roche ranked again the most sustainable healthcare company in the Dow Jones Sustainability Indices
Dec 05, 2016: Changes in Roche Board of Directors
Jan 28, 2016: Changes to the Roche Corporate Executive Committee
Legal and Regulatory
Jul 04, 2016: Infringement procedure against Roche – EMA update
Product News
Oct 03, 2017: Roche launches NAVIFY Tumor Board solution to provide decision support to oncology care teams
Jul 31, 2017: Roche to showcase power of connected lab at AACC 2017 Clinical Lab Expo
Apr 12, 2017: Roche launches antibody test to aid in diagnosis of challenging prostate cancer cases
Nov 21, 2016: Roche launches DISCOVERY 5-Plex procedure for cancer research applications
Aug 02, 2016: Roche introduces virtual reality theater at AACC 2016 Clinical Lab Expo to give lab professionals firsthand glimpse of connected lab of the future
Aug 02, 2016: Roche launches new target enrichment systems for genetic and translational research
Jul 28, 2016: Imanova, in collaboration with Roche and Imperial, characterise radio-tracer for imaging addiction pathways
Jul 15, 2016: CoaguChek PT/ INR devices for use at the point of care and for patient self-testing remain a safe and effective option for patients on anticoagulation therapy
Mar 11, 2016: Roche launches new chromogen for cancer research
Other Significant Developments
Jul 26, 2017: Accenture To Transform Diabetic Patient Care Using Data-driven Analytics Platform
May 19, 2017: med fusion Launches an EGFR Liquid Biopsy Service Based on Roche EGFR Mutation Test
May 06, 2016: Roche Announces Direct Sales of Kapa Biosystems NGS Products in Canada
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

F. Hoffmann-La Roche Ltd, Medical Equipment, Key Facts, 2016
F. Hoffmann-La Roche Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017
F. Hoffmann-La Roche Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017
F. Hoffmann-La Roche Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017
F. Hoffmann-La Roche Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017
F. Hoffmann-La Roche Ltd, Deals By Market, 2011 to YTD 2017
F. Hoffmann-La Roche Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017
Roche Diagnostics to Acquire Tissue Dissection Technology from AvanSci Bio
Genentech Acquires NanoPrint LM60 Microarrayer Platform From Arrayit
Viewics Raises Additional USD10.5 Million in Series B Venture Financing
Omicia Raises USD23 Million in Series B Financing Round
Cota Raises Funds through Venture Financing
Purigen Biosystems Raises USD18.2 Million in Series A Financing
Flatiron Health Raises USD175 Million in Series C Financing
mySugr Raises USD4.8 Million in Venture Financing
Curetis Raises USD18 Million in Extended Series B Venture Financing
GeneWeave Biosciences Raises USD12 Million in Series B Venture Financing
Curetis Raises US$16.3 Million In Series B Financing
MacuLogix Raises US$3.6 Million In Series A Financing
Foundation Medicine Raises US$56 Million In Series B Financing
GeneWeave Raises US$12 Million In Series A Financing Round
GeneWeave Biosciences Raises USD12 Million in Venrture Financing
Aria Diagnostics Secures US$52.7 Million In Series C Venture Financing
Ariosa Diagnostics Secures USD52.7 Million in Series C Funding Round
Curetis Secures Additional US$13.3 Million In Series A Venture Financing
Foundation Medicine Secures Additional US$8.5 Million In Series A Venture Financing
Foundation Medicine Raises US$10 Million In Venture Financing
Ambit Biosciences Secures US$30 Million In Series D-2 Financing
Genentech Enters into Licensing Agreement with Vital Art and Science
Roche Enters into Licensing Agreement with Becton Dickinson
Ariosa Diagnostics Enters into Licensing Agreement with Labs
Foundation Medicine Enters into Licensing Agreement with WuXi PharmaTech
Roche Enters Into Licensing Agreement With Sysmex Inostics For emPCR Patent Portfolio
Thermo Fisher Scientific Extends Licensing Agreement With Roche For Procalcitonin Test
Ventana Medical Systems Enters Into Licensing Agreement With Biocare Medical
Ventana Medical Enters Into Licensing Agreement With German Cancer Research Center And University Hospital Heidelberg For BRAF V600E
Ventana Medical Enters Into Licensing Agreement With Gen-Probe For IP Of ERG Marker
Roche Enters Into Licensing Agreement With Life Technologies For PCR Technology
Ventana Medical Systems Enters Into Licensing Agreement With Cell Signaling Technology
Research Ventures & Licensing Enters Into Licensing Agreement With Ventana Medical Systems
Cell Signaling Technology Enters Into Licensing Agreement With Ventana Medical Systems
Circadian Technologies Enters Into Licensing Agreement With Chugai Pharma
Mimetas and Roche Jointly Develops Gut-On-A-Chip Technology
Roche Enters into Agreement with Accenture
Senseonics Holdings Enters into Agreement with TypeZero and Roche Diabetes
Loxo Oncology Enters into Agreement with Ventana Medical Systems
Roche Diabetes Care Enters into Agreement with Medtronic
Good Start Genetics Enters into Marketing Agreement with Roche Diagnostics
Berkeley Lights Enters into Agreement with F. Hoffmann-La Roche
Roche Enters into Agreement with BARDA
Horizon Discovery Group Enters into Co-Development Agreement with Ventana Medical Systems
Foundation Medicine Enters into Agreement with AstraZeneca
Senseonics Amends its Distribution Agreement with F. Hoffmann-La Roche
Cellnovo Enters into Agreement with Roche Diagnostics
Blueprint Medicines Enters into Co-Development Agreement with Ventana Medical Systems
Foundation Medicine Enters into Agreement with Mirati Therapeutics
IMS Health Enters into Agreement with Foundation Medicine
Halozyme Therapeutics Enters into Co-Development Agreement with Ventana Medical Systems for Cancer Treatment
Foundation Medicine Enters into Co-Development Agreement with Flatiron Health
Molecular Devices Enters into Co-Development Agreement with Roche Diagnostics
Ventana Medical Systems Enters into Co-Development Agreement with ImmunoGen
AstraZeneca Enters into Co-Development Agreement with Roche
Advanced Biological Labs Extends Co-Promotion Agreement with Roche Diagnostics
Bioprocessing Tech Institute Enters Into Agreement with Roche to Develop Cancer Therapeutics
Ventana Medical Systems Enters into Co-Development Agreement with Merck Serono for Companion Diagnostic Test
AUT University Forms Joint Venture with Roche Diagnostics
Ventana Medical Enters into Co-Development Agreement with MedImmune
Ventana Medical Systems Enters Into Co-Development Agreement With Genmab
Foundation Medicine Extends Co-Development Agreement With Clovis Oncology
Ventana Extends Co-Development Agreement With Bayer Pharma
Foundation Medicine Expands Co-Development Agreement With Novartis
Ventana Medical Systems Enters Into Co-Development Agreement With Incyte For Companion Diagnostic Tests
Ventana Medical Systems Enters Into Agreement With Boehringer Ingelheim For Companion Diagnostic Tests
Ariosa Diagnostics Enters Into Agreement With Fleury For Harmony Prenatal Test
Genia Technologies Enters Into Agreement With Columbia University And Harvard Medical To Develop NanoTag DNA Sequencing Technology
Advanced Biological Labs And Roche Diagnostics Enter Into Agreement To Promote Sequencing, Genotyping And Drug Resistance Products
Ascendis Pharma Enters Into Collaboration Agreement with Genentech
Ventana Medical Systems And TGen Enter Into Agreement To Develop Cancer Diagnostic Markers
Ventana Medical And Barco Enter Into Agreement For Digital Pathology Imaging Platform
Foundation Medicine Enters Into Co-Development Agreement With Memorial Sloan-Kettering Cancer Center
Foundation Medicine Enters Into Agreement With Agios Pharma To Develop Cancer Diagnostics
Roche Enters Into Co-Development Agreement With BioLamina For Cell Culture Systems
Ariosa Diagnostics Enters Into Distribution Agreement With The Doctors Laboratory For Harmony Prenatal Test
Epizyme, Eisai And Roche Enter Into Co-Development Agreement For Companion Diagnostic Test
Roche Enters Into Co-Development Agreement With Precision System Science For PCR Instrument
NCM USA Enters Into Co-Development Agreement With Genentech For Clinical Imaging Agents
Foundation Medicine Enters Into Agreement With Eisai For Genomic Profiling And Diagnostic Discovery
Genia Technologies Enters Into Co-Development Agreement With Columbia University And Harvard University
Foundation Medicine Enters Into Co-Development Agreement With Clovis Oncology
Foundation Medicine Extends Co-Development Agreement With Novartis
Hycor Biomedical Enters Into Distribution Agreement With Roche For KOVA
Sysmex Extends Distribution Agreement With Roche
Seattle Genetics And Millennium Pharma Enter Into Co-Development Agreement With Ventana Medical Systems
Roche Enters Into Co-Development Agreement With Technoclone
Ventana Medical Systems Enters Into Co-Development Agreement With Bayer Pharma
Ventana Medical Systems Enters Into Co-Development Agreement With Pfizer
Foundation Medicine Enters Into Co-Development Agreement With Sanofi For Genetic Biomarkers And Potential Diagnostics
AEterna Zentaris Enters Into Co-Development Agreement With Ventana Medical Systems
Syndax Pharma Enters Into Co-Development Agreement With Ventana Medical Systems
Roche Enters Into Joint Venture Agreement With Swiss Federal Institute of Technology, University of Zurich And University Hospital Zurich
Roche Enters Into Technology Integration Agreement With Labcyte
reinnervate Enters Into Technology Integration Agreement With Mirus Bio
Roche Diagnostics Enters Into Research And Development Agreement With DexCom
Roche Diagnostics Enters Into Distribution Agreement With DexCom
Roche Enters Into Distribution Agreement With PerkinElmer
Roche NimbleGen Enters Into Co-Marketing Agreement With Caliper Life Sciences
Roche Enters Into Collaboration With Evotec
University of Geneva, Hopitaux Universitaires de Geneve, SIB And Roche Form Partnership
F. Hoffmann-La Roche Enters Into Co-Development Agreement With Merck
Roche Enters Into Co-Development Agreement With Clovis Oncology
Roche Applied Science Enters Into Partnership With TIB MOLBIOL
Roche Applied Science Enters Into Co-Marketing Agreement With IT-IS Life Sciences
Lonza Enters Into Distribution Agreement With Roche Applied Science
Foundation Medicine Enters Into An Agreement With Novartis
Sonic Healthcare Enters into Licensing Agreement with Ariosa Diagnostics
Roche Enters into Licensing Agreement with Dalcor Pharma
Roche Diagnostics Enters Into Licensing Agreement With Arizona Technology And Columbia University
MBM ScienceBridge Enters Into Licensing Agreement With Roche
Eppendorf Enters Into Licensing Agreement With F. Hoffmann-La Roche
Foundation Medicine Raises USD250 Million in Private Placement of Shares
Ariosa Diagnostics Withdraws IPO
Foundation Medicine Withdraws Public Offering Of Shares For Up To US$150 Million
Foundation Medicine Completes IPO Of Shares For US$122 Million
Roche Prices Public Offering of Bonds Due 2020 for USD600 Million
Roche Prices Public Offering of 0.875% Bonds Due 2025 for USD1.14 Billion
Roche Plans to Raise USD850 Million in Public Offering of Notes
Roche Plans to Raise USD500 Million in Public Offering of Bonds
Roche Plans to Raise USD1.3 Billion in Public Offering of Bonds Due 2021
Roche Plans to Raise USD1.3 Billion in Public Offering of Bonds Due 2024
Roche Plans to Raise USD300 Million in Public Offering of Bonds
Roche Plans to Raise USD1.5 Billion in Public Offering of Bonds
Roche Rumored To Sell Its Diabetes Device Unit
SynenTec To Acquire Cellavista Systems Business From Roche
Roche Acquires mySugr for USD73.1 Million
Roche Acquires ForSight VISION4 from ForSight Labs
Novartis Plans to Sell its Stake in F. Hoffmann-La Roche
Roche Acquires GeneWEAVE BioSciences for USD350 Million
Roche Acquires CAPP Medical
Roche Acquires Signature Diagnostics
Roche Acquires Ariosa Diagnostics
Roche Acquires Bina Technologies
F. Hoffmann-La Roche Completes Acquisition of Iquum for USD450 Million
Roche Diagnostics Acquires Genia for up to USD350 Million
Fluidigm Completes Acquisition Of DVS Sciences For US$207.5 Million
Roche Rumored To Acquire BioMarin Pharma For US$13.5 Billion
Roche Acquires Constitution Medical For US$220 Million
Celltrion Chairman Jung Jin Seo Plans To Sell Controlling Stake In The Company
Roche Completes Acquisition Of Verum Diagnostica For US$15 Million
Roche Completes Acquisition Of mtm Labs
Roche Completes Acquisition Of PVT Probenverteiltechnik And PVT Lab Systems For US$126.14 Million
F. Hoffmann-La Roche Ltd, Key Competitors
F. Hoffmann-La Roche Ltd, Key Employees
F. Hoffmann-La Roche Ltd, Subsidiaries

LIST OF FIGURES

F. Hoffmann-La Roche Ltd, Medical Equipment, Deals by Type, 2011 to YTD 2017
F. Hoffmann-La Roche Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017
F. Hoffmann-La Roche Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017
F. Hoffmann-La Roche Ltd, Medical Equipment, Deals By Market, 2011 to YTD 2017
F. Hoffmann-La Roche Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017
F. Hoffmann-La Roche Ltd, Medical Equipment, Deals by Type, 2011 to YTD 2017
F. Hoffmann-La Roche Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017
F. Hoffmann-La Roche Ltd, Medical Equipment, Deals by Market, 2011 to YTD 2017
Skip to top


Ask Your Question

F. Hoffmann-La Roche Ltd (ROG) - Medical Equipment - Deals and Alliances Profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: